breast cancer

reputation rating ranking
Marketing

Roche tops cancer reputation rankings as AstraZeneca climbs back

AstraZeneca impressed oncology groups, rising to second place on the corporate reputation ranking on the back of strength in breast and lung cancer.
Nick Paul Taylor Jul 2, 2026 6:00am
Gilead

Gilead’s Trodelvy nabs broad FDA approval in front-line TNBC

Jun 24, 2026 5:00pm
Green traffic light

FDA approves breast cancer expansion for Pfizer's Ibrance

Jun 24, 2026 2:48pm
Roche
Favicon Fierce Biotech

Roche oral SERD's 1st-line miss spurs new adjuvant trial

Jun 2, 2026 12:45pm
AZ
Favicon Fierce Biotech

FDA delays ruling on AstraZeneca drug after negative adcomm vote

May 27, 2026 4:43am
race car photo finish speed fast

AZ, Daiichi's Datroway approved in first-line TNBC

May 22, 2026 11:32am